Population pharmacokinetic analysis of doxecitine and doxribtimine in patients with thymidine kinase 2 deficiency and in healthy volunteers

Phase II

Regulatory interactions

Pharmacometrics

Genetic

Bouchene S, Mittur A, Naik H, Dua P, Neldemo I, Ribbing J, Bergstrand M, Khandelwal A.